0.30 | 0.88%
| Price and Volume | |
|---|---|
| Recent Price | 34.56 |
| 52 Week High | 35.00 |
| 52 Week Low | 19.00 |
| Avg. Daily Vol. (Mil) | 0.17 |
| Beta (3 year) | 0.57 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,038.61 |
| Shares Out (Mil) | 30.05 |
| Float (Mil) | 16.05 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.60 |
| Current Ratio | 6.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 119.20 |
| Price/Sales | 4.84 |
| Price/Book | 8.47 |
| Price/Cash Flow | 65.50 |
| Per Share Data | |
| Earnings | 0.29 |
| Sales | 7.15 |
| Book Value | 4.08 |
| Cash Flow | 0.53 |
| Business Summary | |
|---|---|
| Genomic Health, Inc. is engaged in the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. | |
| General Information | |
| 301 Penobscot Drive
Redwood City, CA 94063 |
|
| www.genomichealth.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 511 | |
| CEO: Kimberly J. Popovits | |
| Short Interest | |
| Current Month (Mil) | 2.03 |
| Previous Month (Mil) | 2.01 |
| Short Interest Ratio (Days) | 10.70 |
| Management Effectiveness | |
| Return on Equity | 7.30 |
| Return on Assets | 6.10 |
| Return on Investments | 7.30 |
| Profitability | |
| Gross Margin | 87.40 |
| EBIT Margin | 4.40 |
| Profit Margin | 4.10 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet